ADHD across the lifespan is a single condition with shifting clinical presentation. The childhood presentation is the most recognizable — hyperactivity, impulsivity, attention difficulty, behavioral disruption — and the diagnostic infrastructure is best developed for children. The adult presentation is increasingly recognized but often missed, particularly in women and in patients who developed compensatory strategies that obscured the symptoms. The geriatric presentation is genuinely underrecognized — older adults with lifelong ADHD frequently never received the diagnosis, and the symptoms blend with normal aging in ways that obscure the chronic underlying pattern. The longevity-psychiatry frame engages ADHD as a lifespan diagnosis with implications for cognitive trajectory and treatment that extend across decades.
The childhood presentation has been well-characterized for decades. Diagnosis typically occurs between ages 6 and 12, with classic combined presentation involving hyperactivity, impulsivity, and inattention. The hyperactive-impulsive presentation is more obvious; the predominantly inattentive presentation (more common in girls) is frequently missed. Treatment with stimulants in childhood has the strongest evidence base in psychiatry; long-term cognitive and functional outcomes are substantially better in treated than untreated children, and the prior concerns about long-term safety of childhood stimulant exposure have been substantially addressed by long-follow-up studies.
The adult presentation is more subtle but increasingly recognized. Hyperactivity typically attenuates with age, becoming more internal restlessness than external motor activity. Inattention and executive dysfunction predominate — chronic difficulty with organization, time management, sustained attention, working memory, emotional regulation, and task initiation. The clinical picture often presents as career underachievement despite high apparent ability, chronic relationship difficulty, comorbid anxiety and depression, and substance use patterns that may represent self-medication (caffeine, nicotine, cocaine, alcohol). DSM-5 reduced the childhood-symptom requirement and broadened recognition; the increased adult diagnostic activity in the past decade has identified many previously unrecognized patients.
Late diagnosis in adults often follows specific patterns. Women particularly frequently receive the diagnosis in their 30s or 40s after their children are diagnosed and they recognize the pattern in themselves. High-functioning adults may not present until their compensatory strategies fail — usually with increased responsibility (children, leadership role, multiple competing demands) or with reduced supporting structure (divorce, job loss, retirement). The diagnostic conversation in adults requires the developmental history (childhood symptoms even if subthreshold for childhood diagnosis), the current functional picture, and the exclusion of differential conditions (anxiety, depression, sleep disorders, substance use, trauma sequelae).
The geriatric ADHD picture is the most underrecognized. Older adults with lifelong ADHD may have decades of suboptimal treatment, miscategorized as depressed, anxious, or "scattered." The geriatric presentation includes ongoing executive dysfunction, organizational difficulty, time management problems, working memory challenges, and emotional dysregulation. The clinical recognition matters because treatment in older adults — both stimulant and non-stimulant — is often effective, and the cognitive optimization implications are substantial. The patient who has never been properly treated for lifelong ADHD has likely been carrying suboptimal cognitive function for decades; the treatment that helps in late life is doing real cognitive work.
The longevity-psychiatry implications are significant. Untreated ADHD is associated with elevated risk of substance use disorders, anxiety, depression, accidents, cardiovascular disease (through behavioral and lifestyle pathways), and possibly accelerated cognitive aging. Treated ADHD modifies these risks substantially. The discipline is to recognize ADHD across the lifespan as a treatable condition that contributes to longevity outcomes, to treat it appropriately at every life stage, and to engage the cognitive optimization frame for patients diagnosed late — the prevention prescription matters most when starting later in life. ADHD is not a childhood condition that patients outgrow; it is a lifespan condition that benefits from treatment across the lifespan.